New Antiretroviral Therapy Introduced to Treat Mexico's HIV-AIDS Patients
Prensa Latina
go to original
July 6, 2015
EnglishFrenchSpanish

Stopping HIV? In this episode of VICE Reports, explore the future of Truvada and its revolutionary impact on ending HIV/AIDS. (VICE)

Mexican specialists presented the new antiretroviral therapy denominated Dolutegravir, of GSK pharmaceutical laboratory, to treat patients diagnosed with HIV-AIDS, a disease in which about 180,000 people are suffering in the country.

At a news conference, Luis Enrique Soto, head of the Infectious Diseases Department at the "Salvador Zubiran" National Institute of Medical Sciences and Nutrition, said life expectation of patients with HIV-AIDS, especially when they come in very early stages, is very high.

However, Soto stated that this disease can not be cured, so a safe and responsible sexuality is required.

Read the rest at Prensa Latina

We invite you to add your charity or supporting organizations' news stories and coming events to PVAngels so we can share them with the world. Do it now!

Celebrate a Healthy Lifestyle

Health and WellnessFrom activities like hiking, swimming, bike riding and yoga, to restaurants offering healthy menus, Vallarta-Nayarit is the ideal place to continue - or start - your healthy lifestyle routine.

News & Views to Staying Healthy

From the Bay & Beyond

Discover Vallarta-Nayarit

Banderas Bay offers 34 miles of incomparable coastline in the states of Jalisco and Nayarit, and home to Puerto Vallarta and Riviera Nayarit's many great destinations.